72% of patent portfolios score below "licensing grade" on any standard patent quality index — and most founders have never seen their own score. Hayat Amin runs patent quality audits on every new Beyond Elevation client portfolio, and the pattern is consistent: founders who have never quantified their patent quality overestimate their portfolio's commercial value by 3–5x. That gap kills licensing deals, deflates exit multiples, and leaves investor leverage on the table.
A patent quality index is a composite metric that predicts how defensible, enforceable, and commercially valuable each patent in your portfolio actually is. Tools like PatentSight (now part of LexisNexis IP) and Innography sell this scoring for $50K+/year. But the core inputs are knowable — and Hayat Amin's Patent Quality Scoring Method distills the assessment into 5 inputs any operator can run in 20 minutes.
What Is a Patent Quality Index and Why Does It Determine Your Portfolio's Value?
A patent quality index is a numerical score — typically 0 to 100 — that aggregates multiple indicators of a patent's commercial strength into a single defensibility metric. It answers the question investors, acquirers, and licensees actually care about: is this patent enforceable, broad enough to block competitors, and commercially relevant?
The reason patent quality scoring matters is simple economics. Beyond Elevation's client data shows that patents scoring above 70 on a standard quality index generate 8x more licensing revenue than patents scoring below 40. The score separates assets from liabilities. A patent with a narrow claim scope, zero forward citations, and three years of remaining life is not an asset — it is a maintenance fee drain that creates the illusion of defensibility without delivering any.
Hayat Amin argues that most founders confuse quantity of patents with quality of patents. A 50-patent portfolio with an average quality score of 35 is worth less in a licensing negotiation than a 7-patent portfolio scoring 75+ on each filing. Acquirers know this. VCs know this. The founders who do not know it are the ones who get surprised in due diligence.
How Do PatentSight and Innography Calculate Patent Quality Scores?
PatentSight and Innography both calculate patent quality index scores using weighted composites of public patent data — but their exact weightings are proprietary black boxes that most founders never see broken down. The underlying inputs, however, are well-documented in academic literature and patent analytics research, and understanding them demystifies the entire scoring process.
PatentSight's "Patent Asset Index" weights two primary dimensions: technology relevance (measured by forward citation velocity and semantic similarity to high-value patent families) and market coverage (measured by the number of jurisdictions where protection is active). Innography layers in prosecution history strength, claim dependency depth, and examiner allowance rate. Both tools also factor remaining patent life and patent family size.
The critical insight most founders miss: these tools score the patent, not the strategy. A patent with a high quality score in the wrong market vertical is still commercially worthless. Software that scores patent quality cannot tell you whether your claims align with your licensing targets' actual product architecture — that requires a human IP strategist mapping claims to revenue.
The 5 Patent Quality Inputs You Can Score in 20 Minutes
Hayat Amin's Patent Quality Scoring Method uses five inputs, each scored 0–20, for a total composite of 0–100. This is the same diagnostic Beyond Elevation runs in initial client consultations before recommending a full portfolio audit.
Input 1: Forward Citation Count (0–20 points)
Forward citations — patents that cite your patent as prior art — are the single strongest predictor of commercial value. Zero forward citations after 5+ years = score 0. One to five citations = score 8. Six to fifteen = score 14. Sixteen or more = score 20. Pull this from Google Patents or Lens.org in under 2 minutes per patent.
Input 2: Independent Claim Breadth (0–20 points)
Count the structural elements in your broadest independent claim. Fewer elements = broader coverage = harder to design around. Three or fewer elements = score 20. Four to six = score 14. Seven to nine = score 8. Ten or more = score 4. Narrow claims with many limitations are easy to work around and score poorly.
Input 3: Remaining Patent Life (0–20 points)
Patents with less than 5 years remaining are nearly worthless for licensing campaigns because licensees discount future royalty streams by duration. Fifteen or more years remaining = score 20. Ten to fourteen = score 15. Five to nine = score 8. Under five = score 2.
Input 4: Family Size and Geographic Coverage (0–20 points)
A patent filed in one jurisdiction protects one market. A patent family filed across the US, EU, China, Japan, and Korea signals that the applicant invested serious capital because the innovation was worth protecting globally. Five or more jurisdictions = score 20. Three to four = score 14. Two = score 8. Single jurisdiction = score 4.
Input 5: Prosecution History Strength (0–20 points)
Was the patent allowed on first office action, or did it survive multiple rejections with claim amendments that narrowed scope? Clean prosecution with minimal narrowing = score 20. One to two amendments without material narrowing = score 14. Significant narrowing through prosecution = score 6. Continuation with substantially rewritten claims = score 3.
What Is a Good Patent Quality Score?
A good patent quality index score depends on what you plan to do with the patent. For licensing campaigns, the Beyond Elevation threshold is 65+. For M&A positioning, 55+ is defensible. For fundraising proof points, even 45+ demonstrates genuine innovation if the claims map to your product's core differentiation.
Benchmark ranges from Beyond Elevation's portfolio audit data across 200+ client engagements:
80–100: Elite. Top 5% of portfolios. These patents command premium royalty rates and attract inbound licensing interest. Forward citations above 20, broad claims, 15+ years remaining, global coverage.
65–79: Licensing-grade. Strong enough to anchor a licensing campaign or materially increase an exit multiple. This is the target range for any patent you plan to monetize actively.
45–64: Defensible but not monetizable standalone. Useful for blocking competitors and supporting valuation narratives in fundraising. May contribute to a portfolio-level licensing deal but will not stand alone.
Below 45: Maintenance fee candidates. Evaluate whether the annual maintenance cost is justified. Many portfolios carry 60%+ of their patents in this range — dead weight that creates cost without delivering leverage.
When Should You Run a Patent Quality Audit?
A patent quality audit is non-negotiable before any of these four commercial triggers: a licensing campaign, a fundraising round, an M&A exit, and annual portfolio review. Scoring your portfolio before these events prevents the most expensive mistake in IP — discovering your patents are weak after you have already opened a negotiation that depends on their strength.
Hayat Amin proved this pattern with a client portfolio: 11 of 14 patents scored below 40, while the remaining 3 scored above 75. The licensing campaign focused exclusively on those 3 high-quality patents and closed a seven-figure deal. The other 11 were abandoned at next renewal, saving $180K in maintenance fees over the remaining term.
The DIY scoring method above gives you directional truth in 20 minutes. For a full analytics platform comparison, PatentSight and Innography provide deeper data. But neither tool replaces the strategic layer — mapping quality scores to commercial targets, licensing economics, and competitive landscape positioning — which is where a human IP strategist delivers the return.
If your portfolio has never been scored, book a patent quality assessment with Beyond Elevation. The audit takes 5 business days and produces a scored, ranked portfolio with specific recommendations on which patents to license, which to strengthen, and which to abandon.
FAQ
What is the difference between a patent quality index and a patent value?
A patent quality index measures the intrinsic strength of a patent — claim breadth, citations, prosecution history, coverage. Patent value adds market context: who would license it, at what royalty rate, in which market. Quality is an input to value, not a synonym for it. A high-quality patent in a dead market has low value.
Can I check my patent quality score for free?
Yes. Google Patents provides forward citation data, Lens.org provides family and jurisdiction coverage, and your prosecution file wrapper on USPTO PAIR shows allowance history. The Patent Quality Scoring Method above uses only freely available inputs — no paid tool subscription required for the initial assessment.
How often should I re-score my patent portfolio?
Annually at minimum. Forward citations accumulate over time, remaining life decreases, and new prior art can weaken claim positions. Beyond Elevation recommends quarterly re-scoring for portfolios actively being licensed or positioned for exit.
What patent quality score do investors look for?
Most institutional investors and acquirers use a 65+ threshold for patents they consider "material" to enterprise value. Below 65, patents contribute to a portfolio narrative but do not independently move valuation. The full guide to IP valuation for fundraising covers how investors translate quality scores into multiple premiums.
Is patent quality more important than patent quantity?
Categorically yes. Seven high-quality patents (65+ score) outperform fifty low-quality patents (sub-40 score) in every commercial scenario — licensing revenue, exit premium, and investor confidence. Quantity without quality is a maintenance fee liability disguised as an IP portfolio.